… workers to treat COVID-19 using previously approved or investigational drugs [2]. Here,
we gathered information that may be pertinent to drug discovery for COVID-19 via a systemic …

… Clearly, an immediate emergence of new, effective drugs for COVID-19 has not been an
option because the usual extensive drug development and clinical testing takes 10–15 years. …

… agent of COVID-19. Drug development has been conducted in various ways including …
attention than any of the other drugs and were the targets of intensive investigation early in the …

… Intensive research on SARS-CoV-2 is urgently warranted to understand its pathogenesis …
are discussed intensively. Several molecular docking and systems pharmacology approaches …

SciELO - Brasil - COVID-19: molecular targets, drug repurposing and new avenues for drug
discovery COVID-19: molecular targets, drug repurposing and new avenues for drug …

… trials remain a growing area of interest for reaching methods of controlling COVID-19. …
supplemental oxygen or intensive care and current estimates of COVID-19 case fatality rates vary …

… population against the threat of COVID-19. However, to … approaches for the treatment and
prevention of COVID-19 by … for coronavirus were relatively low after the intensive effort to …

… extensive research on the chemistry or molecular biology/biochemical formulation. Drug
design … , genomics and combinatorial chemistry, drug discovery has advanced in precision and …

… unable to explore the extensive chemical space relevant for drug molecule generation. To
… for drug design by coupling ML with PB methods. We bring together several methods into a …

… the COVID-19 pandemic has been reflected in the extensive … learned from six decades of
antiviral drug discovery 5,6,7,8 , … b, Fragment crystallizable (Fc)-engineering approaches that …